Health Tech Forward Event 2024

L'Institut Català de la Salut vol ressaltar els principals actius de la institució: la plantilla de professionals, l’assistència des de l’embaràs fins a la vellesa, l’abast territorial, un repàs del nombre de centres i el coneixement que promou l’organització a través de formació, la docència, la recerca i la innovació.

Developer of software-based medical devices designed to offer voice-based machine learning software for the early detection of heart failure. The company's digital health platform includes patient monitoring and digital biomarkers and utilizes novel technology to deliver personalized and predictive virtual care at home, enabling people to live longer and happier lives despite their cardiovascular condition.

Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures invests across Europe and North America with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field. We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company. In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. Imprint: https://www.daiichi-sankyo.eu/meta-navigation/imprint All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

LUMO Labs is an impact-driven multi-stage (pre-seed through series A) venture capital fund with coaching program for founding teams. of ventures focused on AI/Data, Blockchain, IoT, VR/AR, and/or Digital Security. We believe these emerging technologies hold the key to solving the social challenges people face today. At LUMO Labs, we focus on sustainable cities and communities, health & Well being, Quality Education, and Climate Action. We create opportunities for people and emerging technologies by connecting impact-driven groundbreaking start-ups to our funds, our expertise, our network and each other. LUMO Labs Eindhoven (the Netherlands) is situated in the heart of the Brainport region where high-tech and design go hand in hand with high-quality manufacturing and entrepreneurship. Collaboration and knowledge-sharing are part of this regions DNA. It is the region where Open Innovation started. Philips Electronics has its origin in the city of Eindhoven. LUMO Labs Los Angeles (United States) is located in Silicon Beach, a booming technology region on the US West Coast. It is home to over 500 tech start-ups, and major technology companies have opened offices in the region. Opposite to Silicon Valley, the L.A. Silicon Beach has a more diversity of industries besides technology. This is in alignment with LUMO Labs multi disciplinary approach.

Withers & Rogers LLP is a leading UK and European firm of patent and trade mark attorneys. Our jurisdiction extends right across Europe as our attorneys represent clients at the European Patent Office, EUIPO - the EU trade mark and design office, and the UK Intellectual Property Office. With over 85 client facing IP professionals spread across six offices, we are able to offer our clients commercially focused intellectual property advice on all aspects of European and international intellectual property law. Our patent, trade mark and registered design attorneys advise on the protection and enforcement of intellectual property rights for inventions, brands, and designs. We have extensive commercial and industrial experience, and our technical expertise spans all major technologies. Withers & Rogers has many long-standing clients both domestic and overseas; we are privileged to represent many prestigious international, brand focused and innovative companies, as well as dynamic SMEs and leading academic institutions. Although based in Europe, we maintain an established worldwide network of contacts including both trusted foreign intellectual property law firms and direct clients. Every year, we invest significant time visiting all major territories to build and maintain these relationships. As such we are able to offer a truly global service in the field of IP to any of our clients.

Operator of a drug discovery and development company intended to identify the genetic underpinnings of rare and common diseases. The company specializes in using bioinformatic approaches and AI to eliminate significant risks associated with traditional drug development as well as sharply reducing the enormous cost, providing patients with the ability to understand their genetic results and how these results guide individual therapies.

At Optum Ventures, we look for exceptional teams with data-driven technologies and services that are poised to deeply disrupt the status quo. By investing in early-stage companies with a transformative vision for making health care better for everyone, we will affect change. We have a goal to connect, accelerate and grow the incredible ideas developed by our portfolio companies with the key health care players that need them most.

The company primarily operates in the Hospitals/Inpatient Services industry. Hospital Universitari Germans Trias i Pujol was founded in 1983 and is headquartered in Badalona, Spain.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world. Our goal is to invest and mentor capital efficient companies that use new scalable business model to improve the efficiency of healthcare delivery from the hospital to the home. HealthTech is now an exploding healthcare market that leverages information technologies to decrease healthcare cost. Historically, venture funding has focused on “Efficacy” (therapeutics drugs and medical devices) and paid little attention to improving “Efficiencies” of healthcare delivery. Today, new paradigm shifting companies like Google, Microsoft, Intel, Apple, Amazon and others are turning their attention to HealthTech. HealthTech supports patient-centric healthcare and is distinct from Healthcare IT, enterprise backbone legacy information systems that are well served by existing major players. Our goal is to invest in capital efficient companies that use new business models to improve the efficiency of healthcare delivery.